Newsfiscal.ai
Jefferies Downgrades Artiva Biotherapeutics to Hold
· Published
Article summary
Jefferies has downgraded Artiva Biotherapeutics from Buy to Hold, setting a price target of $4 per share.
An excerpt from the original article.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…